StockData
BioHarvest Sciences Inc. logo

BioHarvest Sciences Inc. (BHST) income statement

BHSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$1.23+0.01 (+0.82%)

Close on Nov 18, 2026Market cap $27.88MP/E –Yield –

BioHarvest Sciences Inc. income statement

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY2025

Gross margin
59.3%
Operating margin
-16.2%
Net margin
-32.3%
Return on equity, FY2025
-83.2%

Financial strength

Current ratio
3.97
Debt to equity
–
Debt to assets
–
Cash to current liabilities
299.6%

Valuation

P/E ratio
–
Price to sales
0.81
Price to book
1.10
Dividend yield
–

See a number that looks wrong?